Immune endpoint development for chimeric antigen receptor gene therapy

• Research type

  Research Study

• Full title

  Immune endpoint development for chimeric antigen receptor gene therapy

• IRAS ID

  125178

• Contact name

  John Anderson

• Contact email

  j.anderson@ucl.ac.uk

• REC name

  North East - Newcastle & North Tyneside 2 Research Ethics Committee

• REC reference

  13/NE/0090

• Date of REC Opinion

  11 Mar 2013

• REC opinion

  Favourable Opinion